Syneron Medical Ltd. : Syneron Medical to Report First Quarter 2012 Financial Results on May 9, 2012
04/25/2012| 01:19am US/Eastern
Recommend:
Syneron Medical to Report First Quarter 2012 Financial
Results on May 9, 2012
YOKNEAM, ISRAEL -- (MARKET WIRE) -- 04/24/2012 -- Syneron
Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic
device company, today announced that it will release first
quarter 2012 financial results before the market opens on
Wednesday, May 9, 2012. The earnings release will be
available on Syneron's website at www.syneron.com.
Syneron management will host a conference call and a live
webcast at 8:30 a.m. (ET) on the same day. A question &
answer session will follow management's discussion of
events in the first quarter 2012.
Investors and analysts may participate in the conference call
using the following dial-in numbers:
US (toll free): (877) 844-6886
International: (970) 315-0315
The conference passcode for both is 74957731.
Investors and other interested parties can also access a live
webcast of the conference call through the Investor Overview
page on Syneron's website at www.syneron.com. Please log-in
at least 10 minutes prior to the conference call in order to
download the applicable audio software. Following the
conclusion of the call, a replay of the webcast will be
available within 24 hours on the Company's website.
About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global
aesthetic device company with a comprehensive product
portfolio and a global distribution footprint. The
Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through
the treatment of superficial benign vascular and pigmented
lesions, and the treatment of acne, leg veins and cellulite.
The Company sells its products under two distinct brands,
Syneron and Candela. Founded in 2000, the corporate, R&D, and
manufacturing headquarters for Syneron Medical Ltd. are
located in Israel. Syneron also has R&D and manufacturing
operations in the US. The Company markets and services and
supports its products in 90 countries. It has offices in
North America, France, Germany, Italy, Portugal, Spain, UK,
Australia, China, Japan, and Hong Kong and distributors
worldwide.
Contacts: Asaf Alperovitz
Chief Financial Officer
+ 972 73 244 2283
Email: Email Contact
Zack Kubow
The Ruth Group
646-536-7020
Email: Email Contact
distributed by
|
|
Recommend :
